Skip to content
Pharma Observatory a Scientist.com platform
  • Supplier site
  • Group of sites (click to zoom)

Scientist.com supplier network (site locations)

Research supplier

INVIVO BIOTECHNOLOGY

INVIVO BIOTECHNOLOGY is listed as a small business research supplier in the Scientist.com network, with 1 site in 1 country.

View INVIVO BIOTECHNOLOGY on Scientist.com

Sign in to Scientist.com to open this supplier in your organization's marketplace.

Email me this page as a PDF

Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Sites 1
Countries 1

Services

What this research supplier says it provides, as listed in the Scientist.com network.

Type of company: Small business

Disease Models

  • Acute Kidney Failure Models Measure therapeutic endpoints in animal models of acute kidney failure.
  • Auto-immune Hepatitis Models Measure therapeutic endpoints in animal models with auto-immune hepatitis.
  • Bone Models Measure therapeutic endpoints in animal models of bone disorders.
  • Cardiovascular Metabolics Models Measure therapeutic endpoints in animal models of cardiovascular disorders.
  • Cartilage Repair Models Measure therapeutic endpoints in animal models of cartilage repair.
  • Cataract Models Measure therapeutic endpoints in animal models of cataracts.
Show all 52 in Disease Models 46 more
  • Chronic Kidney Disease Models Measure therapeutic endpoints in animal models of chronic kidney disease.
  • Cough Models Test the therapeutic efficacy of drug candidates in cough models.
  • Cyp2f2 Knockout Mouse Study Cyp2f2-mediated lung metabolism.
  • Diabetic Retinopathy Models Assess therapeutic efficacy of drug candidates in diabetic retinopathy models of disease.
  • Dry Eye Models Measure therapeutic endpoints such as tear induction, TBUT, Schirmer strips (tear volume) and cornea staining.
  • Fecal Microbiota Transplantation (FMT) - Mouse Use germ-free mice to evaluate the properties of complex or defined gut microbiota following fecal microbiota transplantation (FMT). Axenic (germ-free) mice transplanted with donor microbiota can be utilized to assess...
  • General Pain Models Measure therapeutic endpoints in animal models of general pain.
  • Hepatitis B Virus Models Measure therapeutic endpoints in animal models of Hepatitis B virus infection.
  • Hepatitis C Virus Models Measure therapeutic endpoints in animal models of Hepatitis C virus infection.
  • IGA Glomerulonephritis Models Measure therapeutic endpoints in animal models of IgA glomerulonephritis.
  • Inflammatory Pain Models Measure therapeutic endpoints in animal models of inflammatory pain.
  • Ischemia Models Measure therapeutic endpoints in animal models of ischemia.
  • Kidney Transplant Models Measure therapeutic endpoints in kidney transplant models.
  • LPS Acute Response Models Measure therapeutic endpoints in acute models of inflammation.
  • LPS Lung Inflammation Models Measure therapeutic endpoints in animal models of inflammation.
  • Macular Degeneration Models Use a single animal species to create one or more models for eye disease.
  • Microdialysis Models Measure the effect of drug candidates on neurotransmission in rat or mouse models.
  • Morris Water Maze Investigate spatial learning and memory in rodents.
  • Myelination Models Measure therapeutic endpoints in animal models with induced myelination, remyelination or developmental myelination.
  • Non Obese Diabetic Mice Use a single animal species to create one or more disease models for diabetes.
  • Obese Mice Use a single animal species to create one or more disease models for diet-induced obesity and type II diabetes.
  • Obstructive Sleep Apnea Rat Study pathologic cardiac changes of obstructive sleep apnea (OSA) in a rat model.
  • Ocular Inflammation Models Measure ocular inflammation in models of eye disorders such as uveitis and keratitis.
  • Ophthalmic Models Test drug candidates in glaucoma, macular degeneration, keratitis, uveitis and CMV retinitis models.
  • Osteoarthritic Pain Models Measure therapeutic endpoints in animal models of osteoarthritic pain.
  • Osteoporosis Models Measure therapeutic endpoints in animal models of osteoporosis.
  • OVA Lung Inflammation Models Measure therapeutic endpoints in animal models of inflammation.
  • Pain Endpoints Models Measure therapeutic endpoints in animal models of pain.
  • Pain Model Consulting Expert advice to better evaluate and understand pain thresholds and phenomena within living organisms. Can be used to evaluate pain associated with specific diseases or injuries affecting the sensory and nervous systems.
  • Pain Models Test therapeutic efficacy of drug candidate in pain model.
  • Parkinson's Disease Models Measure therapeutic endpoints in animal models of Parkinson's disease.
  • Pigmented Rabbit Use a single animal species to create one or more disease models for eye cancer.
  • Precision Cut Lung Slices (PCLS) Use a phenotypically accurate model of lung behavior for screening and target validation.
  • Pulmonary Fibrosis Models Measure therapeutic endpoints in animal models of pulmonary fibrosis.
  • Receptor Occupancy Models Determine the effective dose and concentration needed to reach effective levels in a given tissue.
  • Respiratory Models Test therapeutic efficacy of drug candidate in respiratory disease model.
  • Schizophrenia Models Measure therapeutic endpoints in animal models of schizophrenia.
  • Sclerosis ALS Models Measure therapeutic endpoints in animal models of sclerosis.
  • SHR/NCrl Rat Use a single animal species to create one or more disease models fior hematopoesis.
  • Spinal Cord Injury Models Measure therapeutic endpoints in models of spinal cord injury.
  • Stroke Models Measure therapeutic endpoints in animal models of stroke.
  • Systemic Lupus Erythematosus Models Measure therapeutic endpoints in animal models of immune disorders such as SLE and lupus.
  • Thrombosis Models Measure therapeutic endpoints in animal models of thrombosis.
  • Ventricular Tachycardia Models Measure therapeutic endpoints in animal models of ventricular tachycardia.
  • Visceral Pain Models Measure therapeutic endpoints in animal models of visceral pain.
  • Weanling Rat Use a single animal species to create one or more disease models for anemia.

In Vivo ADME

  • Chronic Bile Duct Cannulation (BDC) Study - Rat Conduct a bile duct cannulation (BDC) study in rats to support the absorption, distribution, metabolism and excretion profiling of your compound.
  • Expired Air Study - Other Species Conduct a study to collect expired air and monitor its radioactivity content in other species.
  • Mass Balance Study - Other Species Conduct a study to investigate the plasma pharmacokinetics and excretion of your compound as well as total radioactivity in other species.

In Vivo Pharmacokinetics

  • Mass Balance Elucidate excretory pathways and organ distribution of a parent drug and metabolites
  • Ocular Pharmacokinetic (PK) Screening - Dog / Canine Conduct a pharmacokinetic screening study in dogs/canines that measures the absorption, distribution, metabolism and excretion of your compound following ocular administration.
  • Ocular Pharmacokinetic (PK) Screening - Rat Conduct a pharmacokinetic screening study in rats that measures the absorption, distribution, metabolism and excretion of your compound following ocular administration.
  • Pharmacokinetic (PK) Screening - Mouse Run pharmacokinetic studies in mice that measure a drug's absorption, distribution, metabolism and excretion.
  • Pharmacokinetic (PK) Screening - Rat Run pharmacokinetic studies in rats that measure a drug's absorption, distribution, metabolism and excretion.
Show all 77 services 63 more

Model Development

  • Animal Precision-Cut Lung Slice Model Acquire a fresh phenotypically-accurate model to study animal lung behavior.
  • Human Precision-Cut Intestinal Slice Model Acquire a fresh phenotypically-accurate model to study human intestinal behavior.
  • Pulmonary Hypertension Animal Model Study the pathology of pulmonary arterial hypertension (PAH) and investigate potential therapies.
  • Surgical Models Create new animal models using techniques such as vascular catherization, soft tissue procedures or device implants.
  • Zucker Rat Use a single animal species to create one or more disease models for cachexia.

Oncology Models

  • Animal Hypoxia Models Measure therapeutic endpoints in hypoxic animal models.
  • Digestive System PDX Patient derived xenografts relating to organs and components of the digestive system. This includes, but is not limited to the Stomach, Intestines, Liver, Colon, Colorectal samples and Gastric samples.
  • Endocrine System PDX Patient derived xenografts related to the endocrine system. PDX related to glands controlling hormone regulation such as the Pituitary glands, Thyroid Glands, Adrenals, and Pancreas.
  • Murine Adenocarcinoma 16 (MAC16) Murine Test for therapeutic efficacy of drug candidates in muscle wasting models.
  • Muscle Wasting Models Measure therapeutic endpoints in animal models of muscle wasting.
  • Nervous System PDX Patient derived xenografts relating to the components of the Nervous System. This includes PDX from the Brain, Spinal Cord, and Nerves.
Show all 8 in Oncology Models 2 more
  • Reproductive System PDX Patient derived xenografts relating to reproductive systems. This includes PDX from reproductive organs such as the Ovaries, Cervix, Breasts, Testes, Prostate, and Scrotum.
  • Urinary System PDX Patient Derived Xenografts relating to organs that comprise the Urinary system. This includes, but is not limited to, samples from the Kidneys, Liver, and Bladder.

Safety Pharmacology

  • Conditioned Place Preference or Aversion Study - Mouse Conduct a study to establish the aversion or conditioned place preference and determine the motivational effect of your compound in mice.
  • Conditioned Place Preference or Aversion Study - Rat Conduct a study to establish the aversion or conditioned place preference and determine the motivational effect of your compound in rats.
  • Cytokine Release Syndrome In Vivo assessment of cytokine release syndrome liability in a humanized mouse
  • Self Administration Study - Rat Conduct a study to investigate the potential addictive characteristics of your compound in rats.

Source: Scientist.com supplier network

Where it operates

Sites by country, with the cities in each.

  • China Shanghai 1 site

Source: Scientist.com supplier network (site locations)

Get the INVIVO BIOTECHNOLOGY report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Sources: Scientist.com supplier network.

Work with INVIVO BIOTECHNOLOGY on Scientist.com

For prices, more details, or to contact INVIVO BIOTECHNOLOGY, visit Scientist.com.

Sign in to Scientist.com to open this supplier in your organization's marketplace.